TokenPost·

TelyRx Q3 Revenue Climbs to $23.1 Million as Net Loss Widens

Your call?

Revenue increased from $12.337 million a year earlier, while basic and diluted loss per share narrowed to $0.06 even as net loss grew.

Share

More news